Vivani Medical Receives FDA Clearance for Trial of Type-2 Diabetes Mini-Implant

Published on 21 Jun 2024 on Exec Edge · via Yahoo Finance

By Karen Roman Vivani Medical, Inc. (Nasdaq: VANI) said the FDA allowed the beginning of a phase 1...

Read the rest of the article

Start tracking your investments with Statfolio

On Thursday, Vivani Medical Inc. (NASDAQ:VANI) initiated screening and enrollment at two centers ...

Benzinga · via Yahoo Finance 19 Dec 2024

On Thursday, Vivani Medical, Inc. (NASDAQ:VANI) announced that the Bellberry Human Research Ethic...

Benzinga · via Yahoo Finance 25 Sep 2024

Vivani Medical Inc. (NASDAQ:VANI) expects to initiate the first clinical study for the NPM-115...

Benzinga · via Yahoo Finance 22 Jul 2024

By Karen Roman Vivani Medical, Inc. (Nasdaq: VANI) said the FDA allowed the beginning of a phase ...

Exec Edge · via Yahoo Finance 21 Jun 2024

Vivani Medical, Inc. (NASDAQ:VANI) announced that the U.S. FDA has cleared its Investigational Ne...

Benzinga · via Yahoo Finance 21 Jun 2024

EXCLUSIVE: Vivani Medical Highlights Weight Loss Data For GLP-1 Implant Supporting Potential Vete...

Benzinga via Yahoo Finance 28 May 2024

U.S. stocks on Friday kicked off the month of March on a positive note, after largely negative...

Guru Focus 1 Mar 2024

Key Insights Vivani Medical's significant individual investors ownership suggests that the key de...

Simply Wall St. via Yahoo Finance 1 Mar 2024

Investing.com 29 Feb 2024

Shares of Bumble Inc. BMBL fell sharply during Wednesday’s session following weak quarterly resu...

Benzinga 28 Feb 2024